WO2003048391A1 - Double buffer system for polymerase chain reaction buffers - Google Patents

Double buffer system for polymerase chain reaction buffers Download PDF

Info

Publication number
WO2003048391A1
WO2003048391A1 PCT/IT2001/000609 IT0100609W WO03048391A1 WO 2003048391 A1 WO2003048391 A1 WO 2003048391A1 IT 0100609 W IT0100609 W IT 0100609W WO 03048391 A1 WO03048391 A1 WO 03048391A1
Authority
WO
WIPO (PCT)
Prior art keywords
hepes
tris
buffer solution
dna
pcr
Prior art date
Application number
PCT/IT2001/000609
Other languages
French (fr)
Inventor
Vincenzo Nigro
Original Assignee
Bio3 Research Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio3 Research Srl filed Critical Bio3 Research Srl
Priority to PCT/IT2001/000609 priority Critical patent/WO2003048391A1/en
Priority to AU2002217426A priority patent/AU2002217426A1/en
Publication of WO2003048391A1 publication Critical patent/WO2003048391A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]

Definitions

  • the present invention relates to the field of molecular biology and more particularly concerns the use, in buffer solutions for DNA amplification techniques, of a double buffer system Tris-Hepes enabling to reach the desired pH value without adding Cloridric Acid or Potassium Iodide, offering maximum stability during temperature variations, maximum stability of the used enzymes, even after a cyclic or extended exposure to high temperature, and maximum amplification uniformity at various temperatures.
  • Said double buffer system is used in a reaction mixture also comprising salts that allows the interactions between DNA helix.
  • those functions are carried out by Potassium Chloride.
  • the specific use of Potassium Glutamate is mentioned because it is universally present in the bacterial environment.
  • PCR polymerase chain reaction
  • PCR consists in the sequential repetition of a single amplification cycle, which comprises tree subsequent steps :
  • the first step is the denaturation reaction: DNA sample undergoes to rapid heating at a temperature around 95° C for approximately one minute. In this way, the DNA molecule loses its secondary structure and the double helix (DNADds) denaturates in two single complementary strains (DNAss) . Each single strain works as a template for the synthesis of an other complementary DNA strain.
  • the second step called annealing or hybridisation, the temperature is lowered around 50-60 °C, and short single strain DNA sequences of 20 bais pair, (called primers) , are added. Those short sequences are absolutely necessary for the reaction prosecution because DNA polymerase can, walking on the template sequence, add nucleotides only if a free 3 'OH end is present.
  • the primers having a known or a random nucleotide sequence (random primers) bound to the regions adjacent to the target sequence only if they show a high level of complementarity.
  • DNA polymerase the enzyme responsible for DNA replication
  • DNA polymerase the enzyme responsible for DNA replication
  • 68-72 °C the temperature at which primers 3' -OH end, of a single DNA strain complementary to the target sequence.
  • primers that are not complementary to the target region are not able to stay bound and do not induce the DNA fragment extension; this phenomenon is responsible for the reaction sequence specificity.
  • the entire cycle is repeated for 20-40 times starting again the process with the denaturation step. In theory, the number of copies obtained raises exponentially, doubling at every cycle, until a plateau is reached where the collected amount of DNA to be amplified is higher than the amount the enzyme can amplify in a single cycle.
  • Thermophylic bacterial polymerases are the most commonly used enzymes because they are stable and active after the repeated heating steps of the denaturation-annealing cycle. In this manner, the target region can be amplified up to 4 x 10 ⁇ times after 25 cycles.
  • Said buffer solutions can comprise compounds that, during the first step, facilitate the denaturation of CG-rich regions and inhibit secondary structures formation; during the second step, eliminate aspecific primer-DNA bounding and stabilise the bounds within the primer-template complex; even more, during the last step, they activate and stabilise DNA polymerase.
  • the main problem related to the preparation of PCR buffer solutions is ensuring enzyme activity preservation, maintaining its characteristic during continuous temperature sudden changes, and guaranteeing pH uniformity during repeated reaction cycles. Moreover, obtaining buffer solution suitable for different
  • TRIS-HC1 a pH decreasing of 0,3 every 10 °C temperature increasing is detected.
  • this system like many other commonly used buffers, cannot control sudden pH decreasing at the denaturation temperature.
  • This pH decreasing causes the depletion of purines (lost of Adenine and Guanine) with the creation of abasic sites, and induces DNA template helix breaking, which cannot be trancripted anymore.
  • Tris-Hepes (base-acid) , unknown in the state of the art, which allows the maintenance of a steady pH during PCR steps, and shows the following further advantages : a) In case of PCR multiplex, when many different DNA fragments must be amplified at the same time, a steady pH at various temperatures allows to obtain a higher reaction yield. b) All the used enzymes (DNA polimerase) show high stability even after a cyclic and extended exposure to high denaturation temperature, because they are well buffered. The double buffer system, object of the invention, each component are provided in the following amount for their final use:
  • the components of the double buffer system Tris-Hepes are in a rate between 8:1 and 1:4; and the best rate is between 4:1 and 1:1.
  • the choice of the best value depends on the characteristic that must be given to the obtained buffer solution.
  • the higher enzyme processivity is detected in the presence of a buffer solution containing Tris-Hepes in a rate of 35:10 and 25:10.
  • a low replication error probability is detected, that probably is due to the loss of enzyme processivity.
  • the invention advantageously provides the double buffer system Tris-Hepes in combination with Potassium Glutamate (that can be replaced with Potassium chloride KCl) for the preparation of buffer solutions.
  • Potassium Glutamate facilitates the use of bacterial enzymes, because usually those enzyme works in the presence of said salt, and allows the use of various DNA polymerase and/or restriction enzymes for post-PCR analysis without needing salt changes in the reaction buffer. Therefore, the buffer solution composition, used in the amplification reaction is as follow:
  • Tris-Hepes Magnesium Chloride, Dithiothreitol, (DTT) and gelatin, are added to the double buffer system Tris-Hepes, in association with Potassium Glutamate (that can be replaced with Potassium chloride KCl) , for the preparation of PCR buffer solutions.
  • the buffer In the form of an aqueous solution the buffer has the following composition in the final concentration used in the amplification reaction. TRIS from 1 to 200 mM HEPES from 1 to 200 mM
  • GELATIN from 0,001 to 1 % Magnesium Chloride is used because it causes the increasing of deoxyribonucleotides triphosphate (dNTP) which catalyses, together with Magnesium ion Mg 2+ , nucleotides polymerisation on the template, thus guaranteeing a higher polymerase catalytic activity especially useful in multiplex PCR.
  • dNTP deoxyribonucleotides triphosphate
  • said buffer solution appears to be particularly good for conventional or quantitative multiplex PCR, conventional PCR of AT-rich sequences and quantitative PCR.
  • the buffer solution of this example gives considerable advantages in multiplex PCR because it allows simultaneously high specific amplification of several DNA fragments, as shown in the attached figure 1.
  • Figure 1 shows the results of a quantitative multiplex PCR on DNA samples containing 10 sequences having a medium length of 190-500 bais pairs in the presence of the buffer solution of the above example or in the presence of other commercially available buffer solutions .
  • the best experimental results were obtained using a buffer solution having the following composition in the final concentration used in the ampli ication reaction:
  • Said buffer solution is prepared in the form of optimal mother solution that is five times more concentrated than the final buffer solution used in the amplification reaction.
  • EXAMPLE 2 Magnesium Sulphate, Ammonium Acetate, DMSO, Glycerol, DTT and gelatin are added to the double buffer system Tris-Hepes, in association with Potassium Glutamate (that can be replaced with Potassium chloride KCl) , for the preparation of PCR buffer solutions.
  • the buffer In the form of an aqueous solution the buffer has the following composition in the final concentration used in the amplification reaction.
  • GLYCEROL from 1 to 12 %
  • Magnesium Sulphate is higher than in other known buffer solutions.
  • This salt causes the increasing of deoxyribonucleotides triphosphate (dNTP) which catalyses, together with Magnesium ion Mg 2+ , nucleotides polymerisation on the template, thus ensuring a higher polymerase catalytic activity especially useful in multiplex PCR and in Long PCR.
  • dNTP deoxyribonucleotides triphosphate
  • the buffer solution of the present example allows to lead the annealing (or hybridisation) reaction in no strict temperature conditions ensuring a high level of reproducibility in several different experimental protocols.
  • said buffer is suitable for the amplification of small amounts of DNA, for example viral DNA, the amplification of long DNA fragments, conventional and quantitative multiplex PCR and quantitative PCR.
  • the buffer solution of this example gives considerable advantages because it allows to maintain reaction efficiency and specificity during considerable changing of primers-template annealing temperature, ensuring the success of the amplification reaction even in case of electronic or human mistakes, as shown in the following table; in the table the results of a PCR are shown, at different annealing temperatures, using commercial buffer and the buffer as described in the above example.
  • Table 2 shows the results of a Long PCR of a 120 Kilobasis DNA fragment between exon 70 and exon 74 of Distrofina gene on chromosome Xp21, in the presence of commercially available enzymes together with commercial available buffers or with the example 2 buffer.
  • the results are shown as rate “Signal-Rumour” where “Signal” is the amplification of the desired length band, “Rumour” is the aspecific amplification and the sign minus (-) means that in standard conditions PCR did not give any amplification.
  • said solution enables a high stability after a long cyclic exposure to the denaturation temperature, as shown in the following table. Table 3
  • Table 3 shows the results obtained with the exposure of different commercially available enzymes, to a temperature of 96 °C , for zero, thirty and ninety minutes in the presence of commercial buffer solutions or the example 2 buffer before carrying out a control PCR following a 24 cycles standard protocol.
  • the results obtained with each enzyme are normalised in comparison with the results obtained from the standard amplification in the presence of the commercial buffer and without exposure at a temperature of 96 °C.
  • Said buffer solution is prepared in the form of optimal mother solution that is five times more concentrated than the final used buffer solution.
  • EXAMPLE 3 Magnesium Sulphate and Ammonium Sulphate are added to the double buffer system Tris-Hepes, in association with Potassium Glutamate (that can be replaced with Potassium chloride KCl) , for the preparation of PCR buffer solutions.
  • the buffer In the form of an aqueous solution the buffer has the following composition in the final concentration used in the amplification reaction.
  • This buffer is particularly suitable for multiplex PCR, for Long PCR, for mutant sequences analysis, for fragmented samples analysis or samples containing limited amount of DNA like viral DNA. This buffer do not damage automatic
  • Said buffer solution is prepared in the form of optimal mother solution that is five times more concentrated than the final buffer solution used in the amplification reaction.

Abstract

The invention relates to buffer solution characterised in that they comprise a double buffer system Tris-Hepes to be used, alone or together with Potassium Glutamate to reach the desired pH level without adding Chloridric Acid or Potassium Iodide. Several preferred embodiments to be used for many different experimental protocols for the DNA analysis of DNA having different chemical-physical characteristics or coming from heterogeneous sources are described.

Description

DOUBLE BUFFER SYSTEM FOR POLYMERASE CHAIN REACTION BUFFERS.
The present invention relates to the field of molecular biology and more particularly concerns the use, in buffer solutions for DNA amplification techniques, of a double buffer system Tris-Hepes enabling to reach the desired pH value without adding Cloridric Acid or Potassium Iodide, offering maximum stability during temperature variations, maximum stability of the used enzymes, even after a cyclic or extended exposure to high temperature, and maximum amplification uniformity at various temperatures. Said double buffer system is used in a reaction mixture also comprising salts that allows the interactions between DNA helix. Usually, in most of the buffer solutions, those functions are carried out by Potassium Chloride. In the present preparation, the specific use of Potassium Glutamate is mentioned because it is universally present in the bacterial environment. The polymerase chain reaction (PCR) is nowadays the faster and most reliable technique for DNA sequences amplification. This method, that has been described for the first time in the US patent No. 4,683,195 and in the US patent No. 4,683,202, changed completely molecular biology because it turned out DNA extraction, amplification and analysis extremely rapid and inexpensive. PCR is based on the basic concept which states that if the two sequences placed close to each end of the DNA fragment, that has to be amplified (called target region) , are known, it is possible to replicate said fragment many times obtaining in a short period of time an enormous number of copies of the same.
PCR consists in the sequential repetition of a single amplification cycle, which comprises tree subsequent steps :
The first step is the denaturation reaction: DNA sample undergoes to rapid heating at a temperature around 95° C for approximately one minute. In this way, the DNA molecule loses its secondary structure and the double helix (DNADds) denaturates in two single complementary strains (DNAss) . Each single strain works as a template for the synthesis of an other complementary DNA strain. In the second step, called annealing or hybridisation, the temperature is lowered around 50-60 °C, and short single strain DNA sequences of 20 bais pair, (called primers) , are added. Those short sequences are absolutely necessary for the reaction prosecution because DNA polymerase can, walking on the template sequence, add nucleotides only if a free 3 'OH end is present. The primers, having a known or a random nucleotide sequence (random primers) bound to the regions adjacent to the target sequence only if they show a high level of complementarity.
During the last step, DNA polymerase (the enzyme responsible for DNA replication) is added, at an optimal temperature of 68-72 °C and this allows the synthesis, starting from the primers 3' -OH end, of a single DNA strain complementary to the target sequence. At this temperature, primers that are not complementary to the target region are not able to stay bound and do not induce the DNA fragment extension; this phenomenon is responsible for the reaction sequence specificity. The entire cycle is repeated for 20-40 times starting again the process with the denaturation step. In theory, the number of copies obtained raises exponentially, doubling at every cycle, until a plateau is reached where the collected amount of DNA to be amplified is higher than the amount the enzyme can amplify in a single cycle. Thermophylic bacterial polymerases are the most commonly used enzymes because they are stable and active after the repeated heating steps of the denaturation-annealing cycle. In this manner, the target region can be amplified up to 4 x 10^ times after 25 cycles.
The use of specific buffer solutions enables reaction yield and specificity optimisation as well as the achievement of a suitable reaction environment for the various primer-template combinations and different application of said method. Said buffer solutions can comprise compounds that, during the first step, facilitate the denaturation of CG-rich regions and inhibit secondary structures formation; during the second step, eliminate aspecific primer-DNA bounding and stabilise the bounds within the primer-template complex; even more, during the last step, they activate and stabilise DNA polymerase.
The main problem related to the preparation of PCR buffer solutions is ensuring enzyme activity preservation, maintaining its characteristic during continuous temperature sudden changes, and guaranteeing pH uniformity during repeated reaction cycles. Moreover, obtaining buffer solution suitable for different
PCR technique application, like the analysis of various types of DNA molecules, for the contemporary amplification of many sequences
(multiplex PCR) , for the amplification of long DNA sequences (Long PCR) , the amplification of sequences having an high rate of bais homology (A/T-rich or G/C-rich) , analysis of mutant sequences, analysis of fragmented DNA samples, or limited amount of template DNA as viral DNA is desiderable. Finally, obtaining buffer solutions that do not damage automatic DNA analysis instruments, for example High efficiency DNA chromatography systems (HPLC and DHPLC) is also desiderable . Nowadays, using the double buffer system
TRIS-HC1, a pH decreasing of 0,3 every 10 °C temperature increasing is detected. As a matter of fact, this system, like many other commonly used buffers, cannot control sudden pH decreasing at the denaturation temperature. This pH decreasing causes the depletion of purines (lost of Adenine and Guanine) with the creation of abasic sites, and induces DNA template helix breaking, which cannot be trancripted anymore.
This phenomenon is directly proportional to the length of PCR reaction products and inversely proportional to the initial DNA template quantity. The invention task is the overcoming of said disadvantage, providing a double buffer system
Tris-Hepes (base-acid) , unknown in the state of the art, which allows the maintenance of a steady pH during PCR steps, and shows the following further advantages : a) In case of PCR multiplex, when many different DNA fragments must be amplified at the same time, a steady pH at various temperatures allows to obtain a higher reaction yield. b) All the used enzymes (DNA polimerase) show high stability even after a cyclic and extended exposure to high denaturation temperature, because they are well buffered. The double buffer system, object of the invention, each component are provided in the following amount for their final use:
TRIS from 1 to 200 mM HEPES from 1 to 200 mM
In the double buffer system, object of the invention, the components of the double buffer system Tris-Hepes are in a rate between 8:1 and 1:4; and the best rate is between 4:1 and 1:1. The choice of the best value depends on the characteristic that must be given to the obtained buffer solution. In particular, the higher enzyme processivity is detected in the presence of a buffer solution containing Tris-Hepes in a rate of 35:10 and 25:10. In the buffer solution having a rate value of 20:10, and consequently a lower pH value, a low replication error probability is detected, that probably is due to the loss of enzyme processivity. Moreover, the invention advantageously provides the double buffer system Tris-Hepes in combination with Potassium Glutamate (that can be replaced with Potassium chloride KCl) for the preparation of buffer solutions. Potassium Glutamate facilitates the use of bacterial enzymes, because usually those enzyme works in the presence of said salt, and allows the use of various DNA polymerase and/or restriction enzymes for post-PCR analysis without needing salt changes in the reaction buffer. Therefore, the buffer solution composition, used in the amplification reaction is as follow:
TRIS from 1 to 200 mM
HEPES from 1 to 200 mM POTASSIUM GLUTAMATE from 1 to 250 mM
It has to be underlined that the use of Potassium Glutamate (that can be replaced by Potassium chloride KCl) for the preparation of PCR buffer solutions is unknown in the state of the art, and its application to PCR is drawn from the fact that said salt is the most abundant in bacteria and its use in buffer solutions enables, as well as possible, the restoration of enzyme natural functional conditions and guarantees its maximum efficiency.
Preferred embodiments characterised in that the base composition, as described above, is used in combination with other compounds like Magnesium Sulphate, Ammonium Sulphate, Ammonium Acetate, Glycerol, Dimetylsulfoxide (DMSO) , Dithiothreitol (DTT) and gelatin, that permit to obtain specific buffer solutions suitable for different PCR protocols, are shown as follows.
EXAMPLE 1
Magnesium Chloride, Dithiothreitol, (DTT) and gelatin, are added to the double buffer system Tris-Hepes, in association with Potassium Glutamate (that can be replaced with Potassium chloride KCl) , for the preparation of PCR buffer solutions. In the form of an aqueous solution the buffer has the following composition in the final concentration used in the amplification reaction. TRIS from 1 to 200 mM HEPES from 1 to 200 mM
POTASSIUM GLUTAMATE from 1 to 250 mM MAGNESIUM CHLORIDE from 4 to 20 mM DTT from 0,01 to 2 mM
GELATIN from 0,001 to 1 % Magnesium Chloride is used because it causes the increasing of deoxyribonucleotides triphosphate (dNTP) which catalyses, together with Magnesium ion Mg2+, nucleotides polymerisation on the template, thus guaranteeing a higher polymerase catalytic activity especially useful in multiplex PCR.
Therefore, said buffer solution appears to be particularly good for conventional or quantitative multiplex PCR, conventional PCR of AT-rich sequences and quantitative PCR.
Furthermore, the buffer solution of this example, gives considerable advantages in multiplex PCR because it allows simultaneously high specific amplification of several DNA fragments, as shown in the attached figure 1.
Figure 1 shows the results of a quantitative multiplex PCR on DNA samples containing 10 sequences having a medium length of 190-500 bais pairs in the presence of the buffer solution of the above example or in the presence of other commercially available buffer solutions . The best experimental results were obtained using a buffer solution having the following composition in the final concentration used in the ampli ication reaction:
TRIS 10 mM
HEPES 10 mM
POTASSIUM GLUTAMATE 50 mM
MAGNESIUM CHLORIDE 7 , 5 mM DTT 0,2 mM
GELATIN 0,01 %
Said buffer solution is prepared in the form of optimal mother solution that is five times more concentrated than the final buffer solution used in the amplification reaction.
EXAMPLE 2 Magnesium Sulphate, Ammonium Acetate, DMSO, Glycerol, DTT and gelatin are added to the double buffer system Tris-Hepes, in association with Potassium Glutamate (that can be replaced with Potassium chloride KCl) , for the preparation of PCR buffer solutions. In the form of an aqueous solution the buffer has the following composition in the final concentration used in the amplification reaction.
TRIS from 1 to 200 mM
HEPES from 1 to 200 mM
POTASSIUM GLUTAMATE from 1 to 250 mM MAGNESIUM SULPHATE from 1 to 20 mM AMMONIUM ACETATE from 5 to 200 mM
DMSO from 0, 05 to 10 %
GLYCEROL from 1 to 12 %
DTT from 0,01 to 2 mM
GELATIN from 0, 001 to 1 %
The used concentration of Magnesium Sulphate is higher than in other known buffer solutions. This salt causes the increasing of deoxyribonucleotides triphosphate (dNTP) which catalyses, together with Magnesium ion Mg2+, nucleotides polymerisation on the template, thus ensuring a higher polymerase catalytic activity especially useful in multiplex PCR and in Long PCR.
The buffer solution of the present example allows to lead the annealing (or hybridisation) reaction in no strict temperature conditions ensuring a high level of reproducibility in several different experimental protocols.
In the laboratory practice, said buffer is suitable for the amplification of small amounts of DNA, for example viral DNA, the amplification of long DNA fragments, conventional and quantitative multiplex PCR and quantitative PCR.
Moreover, the buffer solution of this example gives considerable advantages because it allows to maintain reaction efficiency and specificity during considerable changing of primers-template annealing temperature, ensuring the success of the amplification reaction even in case of electronic or human mistakes, as shown in the following table; in the table the results of a PCR are shown, at different annealing temperatures, using commercial buffer and the buffer as described in the above example.
TABLE 1
Figure imgf000012_0001
As shown in the above table, in the presence of example 2 buffer, the amplification is always specific even when the annealing temperature varies extensively.
Said buffer solution is efficient in the amplification of very long sequences (up to 12kb) , as shown in the following table. TABLE 2
Figure imgf000013_0001
Table 2 shows the results of a Long PCR of a 120 Kilobasis DNA fragment between exon 70 and exon 74 of Distrofina gene on chromosome Xp21, in the presence of commercially available enzymes together with commercial available buffers or with the example 2 buffer. The results are shown as rate "Signal-Rumour" where "Signal" is the amplification of the desired length band, "Rumour" is the aspecific amplification and the sign minus (-) means that in standard conditions PCR did not give any amplification. Moreover, said solution, enables a high stability after a long cyclic exposure to the denaturation temperature, as shown in the following table. Table 3
Figure imgf000014_0001
Table 3 shows the results obtained with the exposure of different commercially available enzymes, to a temperature of 96 °C , for zero, thirty and ninety minutes in the presence of commercial buffer solutions or the example 2 buffer before carrying out a control PCR following a 24 cycles standard protocol. The results obtained with each enzyme are normalised in comparison with the results obtained from the standard amplification in the presence of the commercial buffer and without exposure at a temperature of 96 °C.
The best experimental results were obtained using a buffer solution having the following composition in the final concentration used in the amplification reaction:
TRIS 30 mM
HEPES 10 mM POTASSIUM GLUTAMATE 20 mM
MAGNESIUM SULPHATE 5 mM
AMMONIUM ACETATE 60 mM
DMSO 1 %
GLYCEROL 8 % DTT 0,2 mM
GELATIN 0,01 %
Said buffer solution is prepared in the form of optimal mother solution that is five times more concentrated than the final used buffer solution.
EXAMPLE 3 Magnesium Sulphate and Ammonium Sulphate are added to the double buffer system Tris-Hepes, in association with Potassium Glutamate (that can be replaced with Potassium chloride KCl) , for the preparation of PCR buffer solutions. In the form of an aqueous solution the buffer has the following composition in the final concentration used in the amplification reaction.
TRIS from 1 to 200 mM
HEPES from 1 to 200 mM POTASSIUM GLUTAMATE from 1 to 250 mM
MAGNESIUM SULPHATE from 1 to 20 mM
AMMONIUM SULPHATE from 1 to 70 mM
This buffer is particularly suitable for multiplex PCR, for Long PCR, for mutant sequences analysis, for fragmented samples analysis or samples containing limited amount of DNA like viral DNA. This buffer do not damage automatic
DNA analysis instruments, like DNA liquid phase chromatography (HPLC e DHPLC) , because the buffer solution residues do not interact with the chromatographic phase and do not settle on the chromatographic columns. Moreover, said buffer solution is advantageous because it shows rapid activation capacity when specific DNA polymerases, called "Hot Start" are used. TABLE 4
Figure imgf000017_0001
In table 4 the results obtained from a PCR with "Hot Start" enzymes and in the presence of commercial buffers or example 3 buffer are shown.
The best experimental results were obtained using a buffer solution having the following composition in the final concentration used in the amplification reaction:
TRIS 10 mM
HEPES 20 mM
POTASSIUM GLUTAMATE 10 mM
MAGNESIUM SULPHATE 3 mM
AMMONIUM SULPHATE 10 mM
Said buffer solution is prepared in the form of optimal mother solution that is five times more concentrated than the final buffer solution used in the amplification reaction.

Claims

1. The use of a double buffer system Tris-Hepes for the preparation of PCR buffer solutions.
2. The use of a double buffer system Tris-Hepes according to claim 1 in association with Potassium Glutamate for the preparation of PCR buffer solutions.
3. PCR buffer solution wherein the following components are present in the final concentration used in the amplification reaction: TRIS from 1 to 200 mM
HEPES from 1 to 200 mM
4. PCR buffer solution according to claim 3 wherein the following components are present in the final concentration used in the amplification reaction:
TRIS from 1 to 200 mM
HEPES from 1 to 200 mM
POTASSIUM GLUTAMATE from 1 to 250 mM
5. PCR buffer solution according to claim 3 and 4 having the following composition in the final concentration used in the amplification reaction:
TRIS from 1 to 200 mM
HEPES from 1 to 200 mM
POTASSIUM GLUTAMATE from 1 to 250 mM MAGNESIUM CHLORIDE from 4 to 20 mM
DTT from 0,01 to 2 mM
GELATIN from 0,001 to 1 %
6. PCR buffer solution according to claim 3 and 4 having the following composition in the final concentration used in the amplification reaction: TRIS da 1 a 200 mM
HEPES da 1 a 200 mM
POTASSIUM GLUTAMATE from 1 to 250 mM MAGNESIUM SULPHATE from 1 to 20 mM AMMONIUM ACETATE from 5 to 200 mM DMSO from 0,05 to 10 %
GLYCEROL from 1 to 12 %
DTT from 0, 01 to 2 mM
GELATIN from 0,001 to 1 %
7. PCR buffer solution according to claim 3 and 4 having the following composition in the final concentration used in the amplification reaction: TRIS from 1 to 200 mM
HEPES from 1 to 200 mM
POTASSIUM GLUTAMATE from 1 to 250 mM MAGNESIUM SULPHATE from 1 to 20 mM AMMONIUM SULPHATE from 1 to 70 mM
8. PCR buffer solution according to claim 5 having the following composition in the final concentration used in the amplification reaction: TRIS 10 mM
HEPES 10 mM
POTASSIUM GLUTAMATE 50 mM
MAGNESIUM CHLORIDE 7 , 5 mM
DTT 0,2 mM GELATIN 0,01 %
9. PCR buffer solution according to claim 6 having the following composition in the final concentration used in the amplification reaction:
TRIS 30 mM HEPES 10 mM
POTASSIUM GLUTAMATE 20 mM
MAGNESIUM SULPHATE 5 mM
AMMONIUM ACETATE 60 mM
DMSO 1 % GLYCEROL 8 %
DTT 0 , 2 mM
GELATIN 0,01 %
10. PCR buffer solution according to claim 7 having the following composition in the final concentration used in the amplification reaction:
TRIS 10 mM
HEPES 20 mM
POTASSIUM GLUTAMATE 10 mM
MAGNESIUM SULPHATE 3 mM AMMONIUM SULPHATE 10 mM
11. PCR buffer solution according to claims 2, 4, 5, 6, 7, 8 ,9 ,10 characterised in that Potassium Glutamate is replaced by Potassium Chloride the same concentrations.
PCT/IT2001/000609 2001-12-04 2001-12-04 Double buffer system for polymerase chain reaction buffers WO2003048391A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IT2001/000609 WO2003048391A1 (en) 2001-12-04 2001-12-04 Double buffer system for polymerase chain reaction buffers
AU2002217426A AU2002217426A1 (en) 2001-12-04 2001-12-04 Double buffer system for polymerase chain reaction buffers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2001/000609 WO2003048391A1 (en) 2001-12-04 2001-12-04 Double buffer system for polymerase chain reaction buffers

Publications (1)

Publication Number Publication Date
WO2003048391A1 true WO2003048391A1 (en) 2003-06-12

Family

ID=11133759

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2001/000609 WO2003048391A1 (en) 2001-12-04 2001-12-04 Double buffer system for polymerase chain reaction buffers

Country Status (2)

Country Link
AU (1) AU2002217426A1 (en)
WO (1) WO2003048391A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1706502A2 (en) * 2003-11-26 2006-10-04 Eppendorf Ag Methods and compositions for in vitro amplification of extrachromosomal nucleic acid
EP2107125A1 (en) * 2008-03-31 2009-10-07 Eppendorf Array Technologies SA (EAT) Real-time PCR of targets on a micro-array
EP2909338B1 (en) * 2012-10-22 2018-08-15 Bayer CropScience NV Methods, compositions and devices for amplification of nucleic acids

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106727A (en) * 1989-04-27 1992-04-21 Life Technologies, Inc. Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers
US5334515A (en) * 1991-04-10 1994-08-02 Life Technologies, Inc. Method for altering a nucleotide sequence
US6096880A (en) * 1993-04-15 2000-08-01 University Of Rochester Circular DNA vectors for synthesis of RNA and DNA

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106727A (en) * 1989-04-27 1992-04-21 Life Technologies, Inc. Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers
US5334515A (en) * 1991-04-10 1994-08-02 Life Technologies, Inc. Method for altering a nucleotide sequence
US6096880A (en) * 1993-04-15 2000-08-01 University Of Rochester Circular DNA vectors for synthesis of RNA and DNA

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TAO T ET AL: "Slow conversions among subconductance states of cystic fibrosis transmembrane conductance regulator chloride channel.", BIOPHYSICAL JOURNAL. UNITED STATES FEB 1996, vol. 70, no. 2, February 1996 (1996-02-01), pages 743 - 753, XP001098547, ISSN: 0006-3495 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1706502A2 (en) * 2003-11-26 2006-10-04 Eppendorf Ag Methods and compositions for in vitro amplification of extrachromosomal nucleic acid
JP2007512020A (en) * 2003-11-26 2007-05-17 エッペンドルフ アクチェンゲゼルシャフト Methods and compositions for in vitro amplification of extrachromosomal nucleic acids
EP1706502A4 (en) * 2003-11-26 2007-05-23 Eppendorf Ag Methods and compositions for in vitro amplification of extrachromosomal nucleic acid
EP2107125A1 (en) * 2008-03-31 2009-10-07 Eppendorf Array Technologies SA (EAT) Real-time PCR of targets on a micro-array
EP2909338B1 (en) * 2012-10-22 2018-08-15 Bayer CropScience NV Methods, compositions and devices for amplification of nucleic acids
US10087491B2 (en) 2012-10-22 2018-10-02 Bayer Cropscience Nv Methods, compositions and devices for amplification of nucleic acids

Also Published As

Publication number Publication date
AU2002217426A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
JP2901194B2 (en) DNA sequencing method using Thermus aquaticus DNA polymerase
US9988660B2 (en) Compositions and methods for cDNA synthesis
Bloch A biochemical perspective of the polymerase chain reaction
US9428781B2 (en) Oscillating amplification reaction for nucleic acids
AU2011253427B2 (en) Isothermal amplification of nucleic acid using a mixture of randomized primers and specific primers
AU2013203624B2 (en) Isothermal amplification of nucleic acid using a mixture of randomized primers and specific primers
JP5200302B2 (en) Identification of RNA targets using helicases
US10443094B2 (en) Solid phase isothermal amplification
US10597691B2 (en) Isothermal amplification under low salt condition
WO2014004852A2 (en) Kit for isothermal dna amplification starting from an rna template
JP2004532615A (en) Primers and methods for nucleic acid detection and identification
JPH0391484A (en) Control of contamination caused by proliferation reaction of oligonucleotide dependent nucleic acid
US8309303B2 (en) Reverse transcription and amplification of RNA with simultaneous degradation of DNA
WO2003048391A1 (en) Double buffer system for polymerase chain reaction buffers
EP2922965A1 (en) Method for preventing carry-over contamination in nucleic acid amplification reactions
JP2010063456A (en) Polyanion for improved nucleic acid amplification
JP2008533997A (en) Reverse transcription and RNA amplification with simultaneous degradation of DNA
KR100454172B1 (en) Methods for dna amplification and kits therefor
JP6565147B2 (en) Multiplex PCR method
US20120208242A1 (en) Method and RNA Reactor for Exponential Amplification of RNA
CA2939282C (en) Isothermal amplification under low salt condition
WO2022248874A1 (en) Improvements in or relating to digestion of reaction products
Edition PCR Technology
Jones Principles, Procedures, and Parameters

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP